MGMT and glioblastoma: Zhang et al. demonstrated that miR-181d targets MGMT 3’ UTR, and reported an inverse correlation between miR-181d and MGMT levels in human GBM samples, in particular in those samples in which the MGMT promoter was unmethylated [28].